Purchase Order 75P00221P00092

Award Date 5/25/21
Potential Completion Date 6/24/21
Potential Value $566K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Summit, NJ 07901, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services has awarded a $22,428.00 firm-fixed-price purchase order contract to Seqirus USA Inc., a global biotechnology company, for the delivery of flu vaccines during the 2024-2025 season. This award is not a set-aside contract. Seqirus, through its Seqirus Usa, Inc. division, is a major supplier of influenza vaccines to various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and Human...
This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $101,795.87 firm fixed price contract is for the delivery of flu vaccines and does not have a set-aside designation. Seqirus USA Inc.'s Seqirus Usa, Inc. Division has previously held influenza vaccine contracts with various federal agencies, including the...
This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services to Seqirus USA Inc., a global biotechnology company, for the delivery of influenza vaccines. The contract, valued at $1,608,584.60, does not have a set-aside designation. Seqirus USA Inc. has a history of providing influenza vaccines to various federal government customers, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Department...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $170,702.97 firm fixed price delivery order to Seqirus USA Inc. for influenza vaccinations. Under task order 2022-2023, Seqirus will provide influenza vaccines to support VHA's efforts to protect veterans from influenza. As the prime contractor, Seqirus will deliver the vaccines from its Summit, New Jersey division. The delivery order was issued against an existing governmentwide...
This federal contract award to Seqirus USA Inc. is for the delivery of flu vaccines. The $1,241,993.00 fixed-price purchase order was awarded on June 30, 2020 by the U.S. Department of Health and Human Services and has a completion date of July 30, 2020. Seqirus is a global biotechnology company that specializes in the manufacturing and delivery of influenza vaccines to various federal government agencies. The company has been awarded multiple Indefinite Delivery Contracts (IDCs) with agencies...
Seqirus USA Inc. was awarded a $277,576 firm fixed price contract by the Department of Health and Human Services National Institutes of Health Clinical Center to deliver influenza virus vaccine. Specifically, the contract calls for the delivery of 10-packs of 0.5 ml pre-filled syringes of quadrivalent influenza virus vaccine for the 2021-2022 flu season under the Pharmaceuticals and Drugs Federal Supply Schedule contract. No set-aside designation was used for this award. Performance will take...
The Department of Veterans Affairs Veterans Health Administration awarded a $380,703.54 firm fixed price delivery order contract to Seqirus USA Inc. for influenza vaccines. As the prime contractor, Seqirus will provide flu vaccines to VHA's Veterans Integrated Service Network 5, which serves veterans in parts of New Jersey and Pennsylvania. The contract runs from April 8, 2021 through October 15, 2021 for vaccine delivery to the Summit, New Jersey area. No set aside designation or subcontractors...
The Department of Health and Human Services awarded a $225,812 firm fixed price purchase order to Seqirus USA Inc. for the delivery of flu vaccine QUAD. Seqirus USA Inc. is a global biotechnology company that specializes in influenza vaccines. This award did not use a set-aside. Seqirus USA Inc. has received numerous federal contracts to supply influenza vaccines to agencies such as the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Centers for Disease Control...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $196,435.80 firm fixed price delivery order is for the procurement of flu vaccines, with a completion date of October 15, 2021. Seqirus USA Inc. has previously received several influenza vaccine contracts from federal agencies such as the Department of Defense, Department of Justice Bureau of Prisons, and...

The Department of Health and Human Services awarded a $565,937.98 firm fixed price purchase order to Seqirus USA Inc. for influenza vaccines to support the 2021-2022 flu season. Under this contract, Seqirus will provide FLU VACCINE 2021-2022 to the Office of the Assistant Secretary for Administration, the contracting office within HHS. Place of performance will be Seqirus' Summit, New Jersey facility. The contract period is from May 25, 2021 through June 24, 2021 to ensure vaccine availability prior to the upcoming flu season. No subcontractors or set aside designations were identified. This purchase order will aid HHS' efforts to promote public health through influenza immunization programs.

Generated 12/25/23, 2:28 AM